Hello all, this is my first ever post and I'd really appreciate some thoughts and advice.
My Dad, 65, has recently been diagnosed with prostate cancer that has spread to his spine. At that point PSA was 26. He was started on Degarelix a few days after diagnosis, and today, about 2 weeks later, he had a first meeting with his oncologist.
The oncologist has suggested that Dad gets straight onto chemo (Docetaxel) alongside the Degarelix - I know some studies have suggested this is a good thing, but I do have some concerns and just wanted to hear people's thoughts.
They haven't given Dad a Gleason score as apparently there isn't any point in doing a prostate biopsy as in the oncologists words 'we know what it is'. Is that true? Are there times when it doesn't really matter what the Gleason score is? Is it a bad sign that it is not deemed important?
Also I asked my Dad to raise the possibility of early use of abiraterone/zytiga as we have all seen the recent groundbreaking results from the STAMPEDE trial about the benefits. Apparently the oncologist said that NICE had not granted a licence for abiraterone yet and so this wasn't possible. Is this correct? I thought that abiraterone was available but that this was just a new approach in how early it was introduced. I'm worried my Dad is gonna miss out on what sounds like a bit of a gamechanger in terms of prostate cancer treatment.
Finally my Dad also had a pelvic MRI at the end of last week which said that there was no evidence of any lymph or bone mets in his pelvis (surely a good thing). My Dad had to show this report to the oncologist who apparently had no knowledge the scan even occurred but even after reading it said 'well, it's neither good news or bad news'. Is that right? Im sure it doesn't change the fact that this is a serious situation, but surely it gives a certain amount of positivity.
Just concerned that perhaps this Oncologist isn't the best fit and would be curious to hear the thoughts of others on this and the treatments mentioned above.
Thanks, J